GlaxoSmithKline puts people at the heart of everything they do. The company is committed to meeting the unmet and under-served healthcare needs of India through leadership in affordable pricing and the highest level of compliance standards in the industry.
An Overview of GlaxoSmithKline (GSK)
GSK is a science-led global healthcare company with a purpose to help people do more, feel better, live longer. We have world-leading businesses that research, develop and manufacture innovative pharmaceutical medicines and vaccines.
We put people at the heart of everything we do, with the goal of benefiting more patients in the future. We are committed to meeting the unmet and under-served healthcare needs of India through leadership in affordable pricing and the highest level of compliance standards in the industry. Our goal is to leverage the power of science through new innovations in both preventive and curative healthcare and we are a leader in many therapeutic areas where we provide healthcare solutions.
Product Portfolio and Manufacturing Facilities
Leveraging science to enhance the quality of life, we have an extensive product portfolio that includes prescription medicines and vaccines. We have our existing manufacturing site at Nashik, Maharashtra and an upcoming manufacturing facility at Vemgal, Karantaka. We currently produce over 1,000 crore tablets and capsules and over 40 lakh doses of vaccines to serve patients across the country. With the completion of our state-of-the-art facility at Vemgal, we will have the capacity to produce over 9 billion tablets and capsules a year to serve more patients in India.
Leveraging science to enhance the quality of life, we have an extensive product portfolio that includes prescription medicines and vaccines.
At GSK, we are preparing for the future landscape of healthcare in the country to fulfill our commitment to serve more patients. In an era of increasing price control and rising compliance standards, we are putting in place long-term measures to secure reliable supply that will enable us to reach more patients. We are committed to increase disease awareness through the dissemination of high-quality scientific knowledge. We are also committed to bring cutting-edge innovative products of the future to our patients from our global pipeline.
Stress on Quality
Our leading focus continues, as always, as we put in place high standards, new ways ofworking and launching new products. We will continue to emphasise strong execution of our growth strategies and our legacy of caring for our patients. These will continue to be the priorities around which we build a legacy for the future.